Skip to content
Open access

Multiomic analysis identifies T cell subsets and mechanisms of epithelial interaction in idiopathic pulmonary fibrosis

Sep 2026 · JCI Insight · Vol 11 · 0 citations · 63 references
Medicine

TL;DR

The concept that T cells in IPF adopt nonclassical activation patterns that are driven by epithelial interactions within the fibrotic microenvironment is supported.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease characterized by progressive scarring and respiratory failure. While T cells are elevated in IPF lungs, their contributions to fibrosis beyond inflammation remain poorly understood. Here, we performed multiplex imaging and single-cell RNA and protein profiling on about 90,000 CD3+ T cells from control and fibrotic lungs, revealing 11 distinct subsets of CD4+ and CD8+ T cells, including a rare CD56+ regulatory T cell. In addition to increased T cell numbers in severely fibrotic lungs compared with non-diseased controls, we observed CD4+ and CD8+ T cells localized near epithelial cells and in niches of abnormal epithelium. CXCR4/MIF signaling emerged as a central axis mediating T cell–epithelial interactions, while epidermal growth factor receptor (EGFR) and TGF-β pathways dominated in multiple T cell subsets. Our findings support the concept that T cells in IPF adopt nonclassical activation patterns that are driven by epithelial interactions within the fibrotic microenvironment. These studies provide a foundation for exploring alternative therapeutic strategies in IPF lungs by modulating T cell behavior and communication networks.

Read PDF

Similar papers

Open access Sep 2026

Integrated single-cell TCR analysis across tissue identifies GZMK+CD8+ T cells promoting fibrosis via TGF-β signalling in IPF

Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease with progressive scarring and an unknown aetiology, but the cross-tissue immune network remains poorly understood. Here, we performed paired single-cell RNA sequencing and T cell receptor profiling of lung, mediastinal lymph node, and peripheral b...

B. Yue, Shu-Liang Jing, Qia-Xuan Li et al. · 0 citations
Sep 2026

Pathological Th2 cell activation via STAT6 pathway for pulmonary fibrosis.

A CD28-JAK1/STAT6-Th2-monocyte-derived alveolar macrophage pathway is defined as a mechanistic driver of pulmonary fibrosis and nominate CD28 and STAT6 as actionable immunologic targets that could complement existing antifibrotic therapies.

Yudai Miyashita, T. Kaiho, Raul Piseaux Aillon et al. · 0 citations
Open access Aug 2026

Type I interferon-activated myeloid states are associated with less fibrotic stages in idiopathic pulmonary fibrosis.

Early immune processes in idiopathic pulmonary fibrosis (IPF) are poorly defined. Here, we integrate single-cell transcriptomics of lung digests and bronchoalveolar-lavaged cells (n = 108 patients), subcellular-resolution tissue spatial transcriptomics, and single-cell phospho-CyTOF of blood cells to define myeloid sta...

V. Nathwani, P. Weeratunga, J. Woo et al. · 0 citations
Open access Aug 2026

Dysregulated IL-2 signaling and T-cell subset shifts are associated with eosinophilic esophagitis activity

Eosinophilic esophagitis (EoE) is a chronic immune-mediated disorder of the esophagus. However, the T-cell transcriptional programs distinguishing active disease from remission remain incompletely understood. In this study, we applied single-cell RNA sequencing to esophageal biopsies obtained from normal subjects and p...

Jian Cui, Long-Mei Yu, Rui Wang et al. · 0 citations
Open access Oct 2026

Targeting the CD4+ effector memory T cells re-expressing CD45RA suppressor galectin-7: a multi-omics-guided therapeutic strategy for idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease with limited therapeutic options. Although single-cell and spatial transcriptomics have revealed cellular heterogeneity within the IPF lung microenvironment, the immune drivers with causal relevance remain poorly defined. Here, thro...

Tao Yan, Ji-Chang Liu, Yong Liu et al. · 0 citations
Review Open access Aug 2026

Pathogenic group 2 innate lymphoid cells as drivers of lung fibrosis in severe asthma

Evidence for pathogenic ILC2s in severe asthma provides a mechanistic framework linking chronic type 2 inflammation to persistent airway fibrosis, and therapeutic strategies targeting alarmins, cytokines, CDKs, and steroid-resistance signaling are discussed.

Masaya Matsuda, Yuya Sannomiya, Osamu Kaminuma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.